BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35312002)

  • 1. Integrative Clinical, Radiological, and Molecular Analysis for Predicting Remission and Recurrence of Cushing Disease.
    Moreno-Moreno P; Ibáñez-Costa A; Venegas-Moreno E; Fuentes-Fayos AC; Alhambra-Expósito MR; Fajardo-Montañana C; García-Martínez A; Dios E; Vázquez-Borrego MC; Remón-Ruiz P; Cámara R; Lamas C; Carlos Padillo-Cuenca J; Solivera J; Cano DA; Gahete MD; Herrera-Martínez AD; Picó A; Soto-Moreno A; Gálvez-Moreno MÁ; Castaño JP; Luque RM
    J Clin Endocrinol Metab; 2022 Jun; 107(7):e2938-e2951. PubMed ID: 35312002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
    Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
    J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease.
    Wang F; Catalino MP; Bi WL; Dunn IF; Smith TR; Guo Y; Hordejuk D; Kaiser UB; Laws ER; Min L
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e94-e102. PubMed ID: 33108450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of tissue-based ACTH-antibody assay-guided transsphenoidal resection of pituitary adenomas in Cushing disease.
    Erfe JM; Perry A; McClaskey J; Inzucchi SE; James WS; Eid T; Bronen RA; Mahajan A; Huttner A; Santos F; Spencer D
    J Neurosurg; 2018 Sep; 129(3):629-641. PubMed ID: 29027854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission in Cushing's disease is predicted by cortisol burden and its withdrawal following pituitary surgery.
    Dutta A; Gupta N; Walia R; Bhansali A; Dutta P; Bhadada SK; Pivonello R; Ahuja CK; Dhandapani S; Hajela A; Simeoli C; Sachdeva N; Saikia UN
    J Endocrinol Invest; 2021 Sep; 44(9):1869-1878. PubMed ID: 33453019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive Cushing's Disease: Molecular Pathology and Its Therapeutic Approach.
    Yamamoto M; Nakao T; Ogawa W; Fukuoka H
    Front Endocrinol (Lausanne); 2021; 12():650791. PubMed ID: 34220707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease.
    Ramm-Pettersen J; Halvorsen H; Evang JA; Rønning P; Hol PK; Bollerslev J; Berg-Johnsen J; Helseth E
    BMC Endocr Disord; 2015 Oct; 15():62. PubMed ID: 26499317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.
    Hameed N; Yedinak CG; Brzana J; Gultekin SH; Coppa ND; Dogan A; Delashaw JB; Fleseriu M
    Pituitary; 2013 Dec; 16(4):452-8. PubMed ID: 23242860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.
    Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO
    J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?
    Chee GH; Mathias DB; James RA; Kendall-Taylor P
    Clin Endocrinol (Oxf); 2001 May; 54(5):617-26. PubMed ID: 11380492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of recurrence and remission within 3 years in patients with Cushing disease after successful transnasal adenomectomy.
    Nadezhdina EY; Rebrova OY; Grigoriev AY; Ivaschenko OV; Azizyan VN; Melnichenko GA; Dedov II
    Pituitary; 2019 Dec; 22(6):574-580. PubMed ID: 31506907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].
    Abellán Galiana P; Fajardo Montañana C; Riesgo Suárez PA; Gómez Vela J; Escrivá CM; Lillo VR
    Endocrinol Nutr; 2013 Oct; 60(8):475-82. PubMed ID: 23266144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the histological pseudocapsule in surgery for Cushing disease: rapid postoperative cortisol decline predicting complete tumor resection.
    Monteith SJ; Starke RM; Jane JA; Oldfield EH
    J Neurosurg; 2012 Apr; 116(4):721-7. PubMed ID: 22283193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An early post-operative ACTH suppression test can safely predict short- and long-term remission after surgery of Cushing's disease.
    Uvelius E; Höglund P; Valdemarsson S; Siesjö P
    Pituitary; 2018 Oct; 21(5):490-498. PubMed ID: 30039432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative Predictor of Remission in Cushing Disease.
    Zachariah MA; Cua S; Muhlestein WE; Otto BA; Carrau RL; Kirschner LS; Ghalib LM; Lonser RR; Hardesty DA; Prevedello DM
    Oper Neurosurg (Hagerstown); 2023 Apr; 24(4):460-467. PubMed ID: 36701661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
    Yap LB; Turner HE; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease.
    Amlashi FG; Swearingen B; Faje AT; Nachtigall LB; Miller KK; Klibanski A; Biller BM; Tritos NA
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3770-7. PubMed ID: 26196950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the fibroblast growth factor receptor 4 expression and the G388R functional polymorphism on Cushing's disease outcome.
    Brito LP; Lerário AM; Bronstein MD; Soares IC; Mendonca BB; Fragoso MC
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E271-9. PubMed ID: 20660043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalized Early Postoperative Cortisol and ACTH Values Predict Nonremission After Surgery for Cushing Disease.
    Asuzu D; Chatain GP; Hayes C; Benzo S; McGlotten R; Keil M; Beri A; Sharma ST; Nieman L; Lodish M; Stratakis C; Lonser RR; Oldfield EH; Chittiboina P
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2179-2187. PubMed ID: 28323961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.